Ian Chambers

22.6k total citations · 7 hit papers
85 papers, 17.3k citations indexed

About

Ian Chambers is a scholar working on Molecular Biology, Biomedical Engineering and Genetics. According to data from OpenAlex, Ian Chambers has authored 85 papers receiving a total of 17.3k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 13 papers in Biomedical Engineering and 10 papers in Genetics. Recurrent topics in Ian Chambers's work include Pluripotent Stem Cells Research (61 papers), CRISPR and Genetic Engineering (50 papers) and Renal and related cancers (23 papers). Ian Chambers is often cited by papers focused on Pluripotent Stem Cells Research (61 papers), CRISPR and Genetic Engineering (50 papers) and Renal and related cancers (23 papers). Ian Chambers collaborates with scholars based in United Kingdom, Japan and Netherlands. Ian Chambers's co-authors include Austin Smith, Jennifer Nichols, Hitoshi Niwa, Douglas Colby, Morag Robertson, Tom Burdon, Qi-Long Ying, Susan Tweedie, Sonia Lee and Branko Zevnik and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Ian Chambers

84 papers receiving 17.1k citations

Hit Papers

Formation of Pluripotent Stem Cells in the Mammalian Embr... 1986 2026 1999 2012 1998 2003 2003 1998 2007 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian Chambers United Kingdom 44 15.2k 2.3k 1.7k 1.6k 1.5k 85 17.3k
Susana M. Chuva de Sousa Lopes Netherlands 48 9.0k 0.6× 2.0k 0.9× 1.6k 0.9× 1.5k 0.9× 993 0.7× 187 12.3k
Kathrin Plath United States 60 19.1k 1.3× 3.9k 1.7× 944 0.6× 1.4k 0.8× 811 0.6× 124 21.2k
Victor Ruotti United States 17 12.9k 0.8× 1.9k 0.8× 1.7k 1.0× 1.9k 1.2× 667 0.5× 22 15.0k
Ludovic Vallier United Kingdom 52 10.4k 0.7× 1.5k 0.7× 2.0k 1.2× 2.8k 1.8× 1.1k 0.8× 155 13.1k
Marina Gertsenstein Canada 30 13.1k 0.9× 2.1k 0.9× 510 0.3× 1.5k 0.9× 1.9k 1.3× 130 16.3k
Chad A. Cowan United States 37 10.1k 0.7× 1.6k 0.7× 1.2k 0.7× 1.9k 1.2× 553 0.4× 83 12.5k
Ihor R. Lemischka United States 55 10.0k 0.7× 1.8k 0.8× 739 0.4× 1.1k 0.7× 2.0k 1.4× 121 15.3k
Martín F. Pera Australia 55 10.4k 0.7× 1.1k 0.5× 2.1k 1.3× 2.9k 1.8× 644 0.4× 154 12.5k
Tariq Enver United Kingdom 63 9.2k 0.6× 1.5k 0.6× 563 0.3× 624 0.4× 1.5k 1.0× 174 13.7k
Shulan Tian United States 22 10.8k 0.7× 1.1k 0.5× 1.8k 1.1× 2.1k 1.3× 752 0.5× 53 12.5k

Countries citing papers authored by Ian Chambers

Since Specialization
Citations

This map shows the geographic impact of Ian Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Chambers more than expected).

Fields of papers citing papers by Ian Chambers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Chambers. The network helps show where Ian Chambers may publish in the future.

Co-authorship network of co-authors of Ian Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Chambers. A scholar is included among the top collaborators of Ian Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Chambers. Ian Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giovannantonio, Luca Giovanni Di, Dario Acampora, Daniela Omodei, et al.. (2021). Direct repression of Nanog and Oct4 by OTX2 modulates the contribution of epiblast-derived cells to germline and somatic lineage. Development. 148(10). 8 indexed citations
2.
Chambers, Ian, et al.. (2021). Loss of Resf1 reduces the efficiency of embryonic stem cell self-renewal and germline entry. Life Science Alliance. 4(12). e202101190–e202101190. 3 indexed citations
3.
Mullin, Nicholas P., Joby Varghese, Douglas Colby, et al.. (2020). Phosphorylation of NANOG by casein kinase I regulates embryonic stem cell self‐renewal. FEBS Letters. 595(1). 14–25. 6 indexed citations
4.
Zhang, Man & Ian Chambers. (2019). Segregation of the mouse germline and soma. Cell Cycle. 18(22). 3064–3071. 6 indexed citations
5.
Mistri, Tapan Kumar, et al.. (2018). Dynamic changes in Sox2 spatio-temporal expression promote the second cell fate decision through Fgf4 / Fgfr2 signaling in preimplantation mouse embryos. Biochemical Journal. 475(6). 1075–1089. 24 indexed citations
6.
Festuccia, Nicola, Florian Halbritter, Andrea Corsinotti, et al.. (2018). Esrrb extinction triggers dismantling of naïve pluripotency and marks commitment to differentiation. The EMBO Journal. 37(21). 19 indexed citations
7.
Novo, Clara Lopes, Kashif Ahmed, Ugljesa Djuric, et al.. (2016). The pluripotency factor Nanog regulates pericentromeric heterochromatin organization in mouse embryonic stem cells. Genes & Development. 30(9). 1101–1115. 43 indexed citations
8.
Chambers, Ian, et al.. (2014). Lessons in learning. EMBO Reports. 16(1). 7–13. 4 indexed citations
9.
Navarro, Pablo, Nicola Festuccia, Douglas Colby, et al.. (2012). OCT4/SOX2‐independent Nanog autorepression modulates heterogeneous Nanog gene expression in mouse ES cells. The EMBO Journal. 31(24). 4547–4562. 99 indexed citations
10.
Navarro, Pablo, et al.. (2011). The X-inactivation trans-activator Rnf12 is negatively regulated by pluripotency factors in embryonic stem cells. Human Genetics. 130(2). 255–264. 46 indexed citations
11.
Tsakiridis, Anestis, Elena Tzouanacou, Douglas Colby, et al.. (2009). Expression-independent gene trap vectors for random and targeted mutagenesis in embryonic stem cells. Nucleic Acids Research. 37(19). e129–e129. 12 indexed citations
12.
Silva, José, Jennifer Nichols, Thorold W. Theunissen, et al.. (2009). Nanog Is the Gateway to the Pluripotent Ground State. Cell. 138(4). 722–737. 785 indexed citations breakdown →
13.
Navarro, Pablo, Ian Chambers, Violetta Karwacki-Neisius, et al.. (2008). Molecular Coupling of Xist Regulation and Pluripotency. Science. 321(5896). 1693–1695. 261 indexed citations
14.
Chambers, Ian, José Silva, Douglas Colby, et al.. (2007). Nanog safeguards pluripotency and mediates germline development. Nature. 450(7173). 1230–1234. 1120 indexed citations breakdown →
15.
Fouladi‐Nashta, Ali A., Carolyn Jones, Lisa Mohamet, et al.. (2005). Characterization of the uterine phenotype during the peri-implantation period for LIF-null, MF1 strain mice. Developmental Biology. 281(1). 1–21. 83 indexed citations
16.
Chambers, Ian. (2004). The Molecular Basis of Pluripotency in Mouse Embryonic Stem Cells. Cloning and Stem Cells. 6(4). 386–391. 145 indexed citations
17.
Chambers, Ian & Austin Smith. (2004). Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene. 23(43). 7150–7160. 417 indexed citations
18.
Dani, Christian, Ian Chambers, Stephen R. Johnstone, et al.. (1998). Paracrine induction of stem cell renewal by LIF-deficient cells. Developmental Biology. 203(1). 3 indexed citations
19.
Nichols, Jennifer, Branko Zevnik, Konstantinos Anastassiadis, et al.. (1998). Formation of Pluripotent Stem Cells in the Mammalian Embryo Depends on the POU Transcription Factor Oct4. Cell. 95(3). 379–391. 2622 indexed citations breakdown →
20.
Nichols, Jennifer, Duncan Davidson, Tetsuya Taga, et al.. (1996). Complementary tissue-specific expression of LIF and LIF-receptor mRNAs in early mouse embryogenesis. Mechanisms of Development. 57(2). 123–131. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026